Showing results (21-30 of 62) with videos related to
Sort By:
Pageof 7
British Journal of Cancer|October 12, 2021
Combination of a synthetic retinoid and a DNA demethylating agent induced differentiation of neuroblastoma through retinoic acid signal reprogrammingNaoko Hattori, Kiyoshi Asada, Nozomu Miyajima, et al.Medicine|March 11, 2025
New functional electronic stimulation device for acute cerebrovascular disorder treatment: A preliminary prospective studyTomoo Mano, Yasuyo Kobayashi, Kiyoshi Asada, et al.International Journal of Oncology|July 3, 2010
Fibroblasts associated with cancer cells keep enhanced migration activity after separation from cancer cells: a novel character of tumor educated fibroblastsGenichiro Ishii, Hiroko Hashimoto, Kiyoshi Asada, et al.Journal of Gastroenterology|March 31, 2016
Ipragliflozin, a sodium-glucose cotransporter 2 inhibitor, ameliorates the development of liver fibrosis in diabetic Otsuka Long-Evans Tokushima fatty ratsNorihisa Nishimura, Mitsuteru Kitade, Ryuichi Noguchi, et al.Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|October 1, 2015
Incidence of and risk factors for metachronous gastric cancer after endoscopic resection and successful Helicobacter pylori eradication: results of a large-scale, multicenter cohort study in JapanGenki Mori, Takeshi Nakajima, Kiyoshi Asada, et al.Molecular Medicine Reports|September 18, 2020
Novel oral plasminogen activator inhibitor‑1 inhibitor TM5275 attenuates hepatic fibrosis under metabolic syndrome via suppression of activated hepatic stellate cells in ratsRyuichi Noguchi, Kosuke Kaji, Tadashi Namisaki, et al.Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|September 17, 2013
Hereditary diffuse gastric cancer in a Japanese family with a large deletion involving CDH1Masayoshi Yamada, Takeo Fukagawa, Takeshi Nakajima, et al.Oncology Reports|December 6, 2005
Amelioration of carcinogenesis and tumor growth in the rat liver by combination of vitamin K2 and angiotensin-converting enzyme inhibitor via anti-angiogenic activitiesHitoshi Yoshiji, Shigeki Kuriyama, Ryuichi Noguchi, et al.Hepatology Research : the Official Journal of the Japan Society of Hepatology|August 22, 2006
Angiotensin-II and vascular endothelial growth factor interaction plays an important role in rat liver fibrosis developmentHitoshi Yoshiji, Shigeki Kuriyama, Ryuichi Noguchi, et al.International Journal of Molecular Medicine|April 6, 2006
Amelioration of liver fibrogenesis by dual inhibition of PDGF and TGF-beta with a combination of imatinib mesylate and ACE inhibitor in ratsHitoshi Yoshiji, Shigeki Kuriyama, Ryuichi Noguchi, et al.Pageof 7